Anzeige
Mehr »
Samstag, 28.02.2026 - Börsentäglich über 12.000 News
Wegweisende News: NurExone - Pionier der regenerativen neuronalen Medizin!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von x3news

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
FrEurohold Bulgaria AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014
FrMonbat AD: Consolidated quarterly financial report
FrMonbat AD: Quarterly financial report
FrSopharma AD: Consolidated quarterly financial report
FrVenus AD: Consolidated quarterly financial report
FrStara Planina Hold AD: Consolidated quarterly financial report
FrSopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014
DoEurohold Bulgaria AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014
DoEleven Capital AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014
DoM+S Hydraulic AD: Consolidated quarterly financial report
DoSopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014
MiBulgarian Stock Exchange AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014
MiSopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014
DiTchaikapharma High Quality Medicines AD: Consolidated quarterly financial report
DiTchaikapharma High Quality Medicines AD: Consolidated quarterly financial report
DiSopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014
MoShelly Group SE: Other unregulated information
MoShelly Group SE: Consolidated quarterly financial report
MoAgria Group Holding AD: Consolidated quarterly financial report
MoSopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014
MoStara Planina Hold AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014
20.02.Eurohold Bulgaria AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014
20.02.Sirma Group Holding AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014
20.02.Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014
20.02.Bee Smart Technologies AD: Other unregulated information